Provided by Tiger Trade Technology Pte. Ltd.

Mineralys Therapeutics, Inc.

29.03
-0.2000-0.68%
Post-market: 29.030.00000.00%17:28 EST
Volume:1.19M
Turnover:34.21M
Market Cap:2.30B
PE:-10.14
High:29.15
Open:29.11
Low:28.11
Close:29.23
52wk High:47.65
52wk Low:8.69
Shares:79.14M
Float Shares:55.73M
Volume Ratio:1.16
T/O Rate:2.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8636
EPS(LYR):-3.6632
ROE:-42.14%
ROA:-26.50%
PB:3.99
PE(LYR):-7.92

Loading ...

Mineralys Therapeutics Inc - Topline Results From Explore-Osa Trial Expected in Q1 2026

THOMSON REUTERS
·
Sep 30, 2025

Mineralys Therapeutics falls -4.9%

TIPRANKS
·
Sep 15, 2025

Mineralys Therapeutics Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Sep 11, 2025

Mineralys Therapeutics Is Maintained at Buy by Goldman Sachs

Dow Jones
·
Sep 10, 2025

Mineralys Therapeutics On Pace for Record High Close -- Data Talk

Dow Jones
·
Sep 09, 2025

RA Capital Management, L.P. Reports Acquisition of Common Shares in Mineralys Therapeutics Inc

Reuters
·
Sep 09, 2025

Mineralys Says Lorundrostat Shows 'Meaningful' Blood Pressure Reductions in Phase 3 Trial

MT Newswires Live
·
Sep 05, 2025

Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-Htn Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants With High Unmet Medical Need

THOMSON REUTERS
·
Sep 05, 2025

Mineralys Therapeutics Completes Pricing of $250 Million Equity Offering

Deep News
·
Sep 03, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Rev Group, BorgWarner, TechnipFMC

Reuters
·
Sep 03, 2025

Mineralys Therapeutics Is Maintained at Hold by Jefferies

Dow Jones
·
Sep 03, 2025

U.S. RESEARCH ROUNDUP-BOK Financial, Sable Offshore, Zscaler

Reuters
·
Sep 03, 2025

24H | Alphabet Surges 7%; Apple Jumps 3%; NIO and Zscaler Gain 2%; Alibaba Rises 1%; Skillz Sinks 11%

Tiger Newspress
·
Sep 03, 2025

BRIEF-Mineralys Therapeutics Says It Announces Pricing Of Upsized $250.0 Million Underwritten Public Offering Of Common Stock

Reuters
·
Sep 03, 2025

Mineralys Therapeutics Inc - Prices Upsized Offering of 9,803,921 Shares at $25.50 Each

THOMSON REUTERS
·
Sep 03, 2025

Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock

THOMSON REUTERS
·
Sep 03, 2025

Mineralys Therapeutics Inc - Suspends Prospectus Supplement for Atm Equity Offering - SEC Filing

THOMSON REUTERS
·
Sep 03, 2025

Mineralys Therapeutics Suspends Prospectus Supplement for Common Stock Offering, Sales Agreement Remains Active

Reuters
·
Sep 03, 2025

Mineralys Therapeutics Inc - Announces $175 Mln Public Offering of Common Stock

THOMSON REUTERS
·
Sep 03, 2025

Top Premarket Gainers

MT Newswires Live
·
Sep 02, 2025